Cleary Gottlieb Reps DSM In $1B Martek Acquisition

Law360, New York (December 21, 2010, 6:23 PM EST) -- Nutritional and pharmaceutical conglomerate Royal DSM NV said Tuesday it would pay $1.08 billion in cash to acquire microbial nutritional supplement producer Martek Biosciences Corp., in an effort to expand its offerings.

Heerlen, Netherlands-based DSM said it had reached a deal for a tender offer of $31.50 per Martek share, a 35 percent premium over Monday's closing price.

DSM, with annual sales of €8 billion ($10.5 billion) and 22,700 worldwide employees, said the acquisition would expand its presence in the U.S., particularly in the market for...
To view the full article, register now.